This website uses cookies, pixel tags, and similar technologies (“Cookies”) for the purpose of enabling site operations and for performance, personalisation, and marketing purposes. We use our own Cookies and some from third parties. Only essential Cookies are used by default. By clicking “Accept All” you consent to the use of non-essential Cookies (i.e., functional, analytics, and marketing Cookies) and the related processing of personal data. You can manage your consent preferences by clicking Manage Preferences. You may withdraw a consent at any time by using the link “Cookie Preferences” in the footer of our website.
Our Privacy Notice is accessible here. To learn more about the use of Cookies on our website, please view our Cookie Notice.
Ares is providing a private debt package for Exponent’s buyout of Ireland’s largest pharmaceuticals manufacturer, Chanelle Pharma, according to two sources close to the deal.
We're trusted by 9 of the top 10 Investment Banks
Asset Management firms with more than €52bn of European High Yield AUM
80% of trading desks by estimated European High Yield volume
Leading US & European law firm High Yield franchises
